Citigroup’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$145K Sell
10,344
-5,454
-35% -$73.5K ﹤0.01% 4133
2025
Q4
$177K Sell
15,798
-723
-4% -$8.27K ﹤0.01% 4059
2025
Q3
$191K Sell
16,521
-26,256
-61% -$307K ﹤0.01% 4009
2025
Q2
$524K Sell
42,777
-25,391
-37% -$319K ﹤0.01% 3596
2025
Q1
$977K Buy
68,168
+2,526
+4% +$39.4K ﹤0.01% 3279
2024
Q4
$1.05M Buy
65,642
+6,447
+11% +$128K ﹤0.01% 3332
2024
Q3
$1.42M Buy
59,195
+22,367
+61% +$511K ﹤0.01% 2964
2024
Q2
$734K Buy
36,828
+3,328
+10% +$64.8K ﹤0.01% 3124
2024
Q1
$667K Buy
33,500
+4,897
+17% +$94.7K ﹤0.01% 3352
2023
Q4
$642K Buy
28,603
+10,736
+60% +$222K ﹤0.01% 3216
2023
Q3
$361K Sell
17,867
-20,360
-53% -$462K ﹤0.01% 3300
2023
Q2
$977K Buy
38,227
+12,308
+47% +$324K ﹤0.01% 2859
2023
Q1
$771K Sell
25,919
-5,963
-19% -$173K ﹤0.01% 2768
2022
Q4
$863K Buy
31,882
+9,409
+42% +$230K ﹤0.01% 2750
2022
Q3
$489K Buy
22,473
+915
+4% +$23.9K ﹤0.01% 3249
2022
Q2
$589K Sell
21,558
-20,209
-48% -$581K ﹤0.01% 3087
2022
Q1
$1.4M Buy
41,767
+4,573
+12% +$147K ﹤0.01% 2653
2021
Q4
$1.29M Buy
37,194
+11,132
+43% +$360K ﹤0.01% 2987
2021
Q3
$813K Sell
26,062
-932
-3% -$31.6K ﹤0.01% 3242
2021
Q2
$981K Buy
26,994
+22,352
+482% +$924K ﹤0.01% 3245
2021
Q1
$203K Sell
4,642
-6,774
-59% -$318K ﹤0.01% 3999
2020
Q4
$523K Buy
11,416
+7,487
+191% +$312K ﹤0.01% 4164
2020
Q3
$130K Sell
3,929
-12,959
-77% -$414K ﹤0.01% 4913
2020
Q2
$496K Buy
16,888
+1,407
+9% +$40.7K ﹤0.01% 4278
2020
Q1
$417K Buy
15,481
+4,582
+42% +$137K ﹤0.01% 4038
2019
Q4
$367K Buy
10,899
+7,364
+208% +$267K ﹤0.01% 4695
2019
Q3
$132K Sell
3,535
-4,856
-58% -$185K ﹤0.01% 5474
2019
Q2
$366K Buy
8,391
+5,356
+176% +$229K ﹤0.01% 4733
2019
Q1
$129K Sell
3,035
-15,322
-83% -$686K ﹤0.01% 5508
2018
Q4
$822K Buy
18,357
+5,733
+45% +$300K ﹤0.01% 3598
2018
Q3
$865K Buy
12,624
+2,151
+21% +$138K ﹤0.01% 3653
2018
Q2
$491K Sell
10,473
-33,338
-76% -$1.76M ﹤0.01% 4131
2018
Q1
$2.02M Sell
43,811
-39,778
-48% -$1.89M ﹤0.01% 2593
2017
Q4
$3.86M Sell
83,589
-2,077
-2% -$95.5K 0.01% 2084
2017
Q3
$3.86M Buy
85,666
+14,100
+20% +$602K 0.01% 2011
2017
Q2
$2.81M Buy
71,566
+59,036
+471% +$2.23M 0.01% 2231
2017
Q1
$477K Sell
12,530
-51,592
-80% -$2.01M ﹤0.01% 3907
2016
Q4
$2.37M Buy
64,122
+38,344
+149% +$1.37M ﹤0.01% 2733
2016
Q3
$894K Buy
25,778
+11,243
+77% +$394K ﹤0.01% 3340
2016
Q2
$472K Sell
14,535
-28,685
-66% -$879K ﹤0.01% 3727
2016
Q1
$1.24M Buy
43,220
+19,568
+83% +$521K ﹤0.01% 3078
2015
Q4
$790K Buy
23,652
+12,504
+112% +$389K ﹤0.01% 3390
2015
Q3
$317K Sell
11,148
-11,158
-50% -$389K ﹤0.01% 4153
2015
Q2
$904K Sell
22,306
-820
-4% -$36.8K ﹤0.01% 3227
2015
Q1
$1.14M Sell
23,126
-4,523
-16% -$210K ﹤0.01% 2981
2014
Q4
$1.26M Buy
+27,649
New +$1.09M ﹤0.01% 2899

Other funds holding AVNS